Bayer AG
PolandAll drugs from this manufacturer
-
The medicine is used as hormone replacement therapy in postmenopausal women. It helps to relieve symptoms such as hot flashes and prevents osteoporosis in women at high risk of fractures for whom other methods cannot be used.
Dosage form: tablets, film-coated
Active substance Dosage estradiol 1 mg drospirenone 2 mg ATC: G03FA01
-
It is a contrast agent used during magnetic resonance imaging (MRI) scans. It allows for more accurate imaging of various parts of the body, such as the brain, spine, abdomen, heart, blood vessels, or joints.
Dosage form: solution for injection
Active substance Dosage gadobutrol 604.72 mg ATC: V08CA09
-
The medicine is used in the treatment of type 2 diabetes (non-insulin-dependent), especially in overweight individuals for whom diet and exercise alone have not yielded sufficient results. It works by delaying the digestion of carbohydrates, which prevents sudden spikes in blood sugar levels after meals.
Dosage form: tablets
Active substance Dosage acarbose 100 mg ATC: A10BF01
-
The medicine is used in the treatment of type 2 diabetes (non-insulin-dependent), especially in overweight individuals for whom diet and physical activity alone have not yielded sufficient results. It works by delaying the digestion of carbohydrates, which reduces post-meal blood sugar spikes.
Dosage form: tablets
Active substance Dosage acarbose 50 mg ATC: A10BF01
-
The medicine is used for contraception (contraceptive effect) and for the treatment of excessive menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
ATC: G02BA03
-
It is used for contraception (to prevent pregnancy) and for the treatment of heavy menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
Active substance Dosage levonorgestrel 52 mg, 20 mcg/24 h ATC: G02BA03
-
The medicine is used for contraception (preventing pregnancy) and for the treatment of heavy menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
ATC: G02BA03
-
The medicinal product is used to prevent pregnancy (acts as contraception) and to treat heavy menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
Active substance Dosage levonorgestrel 52 mg/20 mcg/24 h ATC: G02BA03
-
It is used for contraception (preventing pregnancy) and for the treatment of heavy menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
Active substance Dosage levonorgestrel 52 mg, 20 mcg/24 h ATC: G02BA03
-
This system is used for contraception (contraceptive effect) and for the treatment of heavy menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
Active substance Dosage levonorgestrel 52 mg, 20 µg/24 h ATC: G02BA03
-
It is used for contraception (to prevent pregnancy) and for the treatment of heavy menstrual bleeding of unknown origin.
Dosage form: system for transdermal delivery
Active substance Dosage levonorgestrel 52 mg, 20 µg/24 h ATC: G02BA03
-
The drug is used to prevent and treat neurological damage caused by cerebral vasospasm occurring after subarachnoid hemorrhage resulting from an aneurysm rupture.
Dosage form: solution for infusion
Active substance Dosage nimodipine 0.2 mg/ml ATC: C08CA06
-
The drug is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the prevention and treatment of ischemic neurological deficits resulting from cerebral vasospasm following subarachnoid hemorrhage caused by an aneurysm rupture.
Dosage form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
-
The medicine is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the oral continuation of treatment and prevention of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Dosage form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
-
The medicine is used to prevent cerebral ischemia by dilating blood vessels. It is indicated for the oral continuation of treatment and the prevention of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage resulting from an aneurysm rupture.
Dosage form: tablets, film-coated
Active substance Dosage nimodipine 30 mg ATC: C08CA06
-
The medicine is used in the case of endometriosis and bleeding resulting from functional disorders.
Dosage form: tablets
Active substance Dosage norethisterone acetate 5 mg ATC: G03DC02
-
It is a contrast medium used in X-ray examinations (diagnostics). Due to its iodine content, it allows for the visualization of veins, arteries, and changes in the kidneys, brain, heart, breasts, and body cavities in radiological images.
Dosage form: solution for injection
Active substance Dosage iopromide 623.4 mg/ml ATC: V08AB05